{
  "docId": "019de073-dc46-770c-87a2-2b21d91043e5",
  "docSlug": "4f9fcbb83e828aea5419518c9cca9ae9",
  "documentTitle": "Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides",
  "authorId": "tonix-pharmaceuticals",
  "authorName": "Tonix Pharmaceuticals",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 27,
  "pageCount": 29,
  "prevPage": 26,
  "nextPage": 28,
  "slideType": "other",
  "function": "other",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": "The slide uses a grid-like layout to associate logos of institutions with specific TNX drug candidates.",
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de073-dc46-770c-87a2-2b21d91043e5/27",
  "deckHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5",
  "deckJsonHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5.json",
  "deckAnchorHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5#slide-27",
  "components": [
    {
      "bbox": {
        "h": 0.7,
        "w": 0.75,
        "x": 0.04,
        "y": 0.00115
      },
      "kind": "image",
      "text": "Logos of MGH, Harvard, Stanford, Geneva, Alberta, Southern Research, Inserm, CHU, Aix-Marseille, Kansas State, Columbia",
      "attrs": null,
      "subkind": "logo-grid",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "10b3a69e-6d6e-41b3-91a2-e2751792b4a3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.35,
        "x": 0.04,
        "y": 0.0052
      },
      "kind": "paragraph",
      "text": "TNX-1900: MIGRAINE & OTHER INDICATIONS",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "48998857-72e6-4c4f-8ad0-d786e9ddcecf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.45,
        "x": 0.44,
        "y": 0.0056
      },
      "kind": "paragraph",
      "text": "TNX-801: SMALLPOX AND MONKEYPOX VACCINE\nTNX-1850: COVID-19 VACCINE",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "58cdf0e3-44bf-4c0a-964b-58396de6bb42",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.45,
        "x": 0.44,
        "y": 0.00275
      },
      "kind": "paragraph",
      "text": "TNX-1300: COCAINE INTOXICATION\nTNX-1700: GASTRIC AND COLORECTAL CANCERS\nTNX-3600: MONOCLONAL ANTIBODIES FOR COVID-19 TREATMENT",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5e25bca9-8dd6-41fd-8597-da8fc9d1d0b6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.45,
        "x": 0.44,
        "y": 0.0078
      },
      "kind": "paragraph",
      "text": "TNX-3700: COVID-19 VACCINE (ZINC NANOPARTICLE mRNA TECHNOLOGY)\nTNX-2300: BOVINE PARAINFLUEZNA VIRUS",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "72a4078f-ccb7-4637-93dc-975f5ece715d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.35,
        "x": 0.04,
        "y": 0.00275
      },
      "kind": "paragraph",
      "text": "TNX-1500: ALLOGRAFT REJECTION",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9058ceba-bcd4-45a1-8475-650b316e6d53",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.35,
        "x": 0.04,
        "y": 0.0078
      },
      "kind": "paragraph",
      "text": "TNX-2900: PRADER-WILLI SYNDROME",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "facf6813-2e56-44b1-872b-1d37f2c01a82",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.35,
        "x": 0.04,
        "y": 0.08
      },
      "kind": "title",
      "text": "Key Development Partners",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3415abf4-e746-4ad5-9496-3961bf01d7b3",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 29,
      "from": 3,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "e532f435-d20e-4323-8595-44dab22c3ce1",
      "evidence": "The presentation uses a golden circle structure to communicate the company's mission and vision",
      "position": 0,
      "objective": "Why Tonix Pharmaceuticals?",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.6,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}